Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT02916173
Clinical Trials · NCT02916173
Triggering of Follicular Maturation
Completed
Phase 3
Gonadorelin
(Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Assiut University
Enrollment
160
Start date
Nov 2016
Locations
1 site, Egypt
Primary endpoint
Number of M II oocytes in both groups
View Gonadorelin compound reference